FIELD: biotechnology.
SUBSTANCE: invention relates to the production of intermediate compounds for the production of drugs. A method for the production of a compound of the formula J-15 or its salt is proposed, where X is Br; PG1 is a protective group for carboxylic acid; PG2 is an amino protective group, and PG3 is an amino protective group. The method includes: (a) interaction of a compound of the formula J-14 or its salt with hydrazine to obtain the compound of the formula J-15, and (b) optionally, formation of salt of the compound J-15. Compounds of formulas J-14, J-15 and a method for the production of a compound of the formula J-16 are also proposed.
EFFECT: obtainment of intermediate compounds for JAK inhibitors.
20 cl, 3 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
HETEROCYCLIC COMPOUNDS EFFECTIVE AS ANABOLIC AGENTS FOR CATTLE | 2007 |
|
RU2419621C2 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
CRYSTAL FORMS OF JAK INHIBITOR COMPOUND | 2018 |
|
RU2790535C2 |
PHENOXYMETHYL HETEROCYCLIC COMPOUNDS | 2009 |
|
RU2531274C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
METHODS FOR TREATMENT USING JAK INHIBITOR COMPOUND | 2018 |
|
RU2764979C2 |
Authors
Dates
2022-12-20—Published
2019-09-03—Filed